+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

From
From
Proto-oncogene protein c mdm2 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto-oncogene protein c mdm2 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Analyzing the Global Pharmaceutical Industry 2022 - Product Thumbnail Image

Analyzing the Global Pharmaceutical Industry 2022

  • Report
  • November 2022
  • 500 Pages
  • Global
From
Drug Analysis: Invokana - Product Thumbnail Image

Drug Analysis: Invokana

  • Drug Pipelines
  • February 2018
  • 33 Pages
  • Global
From
From
From
From
Biotechnology Services Global Market Report 2024 - Product Thumbnail Image

Biotechnology Services Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Loading Indicator